The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Neurotoxicity and Neurodegeneration When PrP Accumulates in the Cytosol
Open accessAbstract
Changes in prion protein (PrP) folding are associated with fatal neurodegenerative disorders, but the neurotoxic species is unknown. Like other proteins that traffic through the endoplasmic reticulum, misfolded PrP is retrograde transported to the cytosol for degradation by proteasomes. Accumulation of even small amounts of cytosolic PrP was strongly neurotoxic in cultured cells and transgenic mice. Mice developed normally but acquired severe ataxia, with cerebellar degeneration and gliosis. This establishes a mechanism for converting wild-type PrP to a highly neurotoxic species that is distinct from the self-propagating PrP Sc isoform and suggests a potential common framework for seemingly diverse PrP neurodegenerative disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prusiner, S. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13363 · Cited by 5,373
Intracellular Functions of N-Linked Glycans
Helenius, A., & Aebi, A. M. (2001) · Science · doi:10.1126/science.291.5512.2364 · Cited by 2,405
Aggresomes: A Cellular Response to Misfolded Proteins
Johnston, J. A., Ward, C. L., & Kopito, R. R. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.7.1883 · Cited by 2,148
Mice devoid of PrP are resistant to scrapie
Büeler, H., Aguzzi, A., Sailer, A., Greiner, R.-A., Autenried, P., Aguet, M., & Weissmann, C. (1993) · Cell · doi:10.1016/0092-8674(93)90360-3 · Cited by 2,100
Prion Diseases of Humans and Animals: Their Causes and Molecular Basis
Collinge, J. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.519 · Cited by 1,344
Ecdysone-inducible gene expression in mammalian cells and transgenic mice.
No, D., Yao, T. P., & Evans, R. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3346 · Cited by 849
Normal host prion protein necessary for scrapie-induced neurotoxicity
Brandner, S., Isenmann, S., Raeber, A., Fischer, M., Sailer, A., Kobayashi, Y., Marino, S., Weissmann, C., & Aguzzi, A. (1996) · Nature · doi:10.1038/379339a0 · Cited by 810
Protein Glucosylation and Its Role in Protein Folding
Parodi, A. J. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.69 · Cited by 658
Caughey, B., & Raymond, G. J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55257-1 · Cited by 637
Transmission of the BSE Agent to Mice in the Absence of Detectable Abnormal Prion Protein
Lasmézas, C. I., Deslys, J.-P., Robain, O., Jaegly, A., Beringue, V., Peyrin, J.-M., Fournier, J.-G., Hauw, J.-J., Rossier, J., & Dormont, D. (1997) · Science · doi:10.1126/science.275.5298.402 · Cited by 582
Cited by
Protein aggregation and neurodegenerative disease
Ross, C. A., & Poirier, M. A. (2004) · Nature Medicine · doi:10.1038/nm1066 · Cited by 3,454
Gaggelli, E., Kozlowski, H., Valensin, D., & Valensin, G. (2006) · Chemical Reviews · doi:10.1021/cr040410w · Cited by 1,729
Stefani, M., & Dobson, C. M. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0464-5 · Cited by 1,651
Caughey, B., & Lansbury, P. T. (2003) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.26.010302.081142 · Cited by 1,650
A General Model of Prion Strains and Their Pathogenicity
Collinge, J., & Clarke, A. R. (2007) · Science · doi:10.1126/science.1138718 · Cited by 1,057
The Ubiquitin Proteasome System in Neurodegenerative Diseases
Ciechanover, A., & Brundin, P. (2003) · Neuron · doi:10.1016/s0896-6273(03)00606-8 · Cited by 982
Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs
Forman, M. S., Trojanowski, J. Q., & Lee, V. M.-Y. (2004) · Nature Medicine · doi:10.1038/nm1113 · Cited by 715
“In prion disease, recent data suggest that the PrP SC can be distinguished from the neurotoxic specie”
BackgroundQuality control in the endoplasmic reticulum protein factory
Sitia, R., & Braakman, I. (2003) · Nature · doi:10.1038/nature02262 · Cited by 688
Physiology of the prion protein
Linden, R., Martins, V. R., Prado, M. A. M., Cammarota, M., Izquierdo, I., & Brentani, R. R. (2008) · Physiological Reviews · doi:10.1152/physrev.00007.2007 · Cited by 617
Aguzzi, A., & Polymenidou, M. (2004) · Cell · doi:10.1016/s0092-8674(03)01031-6 · Cited by 544
Prions: Protein Aggregation and Infectious Diseases
Aguzzi, A., & Calella, A. M. (2009) · Physiological Reviews · doi:10.1152/physrev.00006.2009 · Cited by 504
The cellular prion protein (PrPC): Its physiological function and role in disease
Westergard, L., Christensen, H. M., & Harris, D. A. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2007.02.011 · Cited by 433
The surprising complexity of signal sequences
Hegde, R. S., & Bernstein, H. D. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.08.004 · Cited by 424
Guerriero, C. J., & Brodsky, J. L. (2012) · Physiological Reviews · doi:10.1152/physrev.00027.2011 · Cited by 418
The Prion's Elusive Reason for Being
Aguzzi, A., Baumann, F., & Bremer, J. (2008) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.31.060407.125620 · Cited by 418
The two faces of protein misfolding: gain‐ and loss‐of‐function in neurodegenerative diseases
Winklhofer, K. F., Tatzelt, J., & Haass, C. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601930 · Cited by 401
Are amyloid diseases caused by protein aggregates that mimic bacterial pore-forming toxins?
Lashuel, H. A., & Lansbury, P. T. (2006) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583506004422 · Cited by 400
Calpain-Mediated Signaling Mechanisms in Neuronal Injury and Neurodegeneration
Vosler, P. S., Brennan, C. S., & Chen, J. (2008) · Molecular Neurobiology · doi:10.1007/s12035-008-8036-x · Cited by 382
Molecular Mechanisms of Prion Pathogenesis
Aguzzi, A., Sigurdson, C., & Heikenwaelder, M. (2008) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.3.121806.154326 · Cited by 351
Weissmann, C. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro1025 · Cited by 346
Approval Summary for Bortezomib for Injection in the Treatment of Multiple Myeloma
Bross, P. F., Kane, R., Farrell, A. T., Abraham, S., Benson, K., Brower, M. E., Bradley, S., Gobburu, J. V., Goheer, A., Lee, S.-L., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0781 · Cited by 343
Transmissible spongiform encephalopathies
Collins, S. J., Lawson, V. A., & Masters, C. L. (2004) · The Lancet · doi:10.1016/s0140-6736(03)15171-9 · Cited by 339
Insights into prion strains and neurotoxicity
Aguzzi, A., Heikenwalder, M., & Polymenidou, M. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2204 · Cited by 329
Getting a Grip on Prions: Oligomers, Amyloids, and Pathological Membrane Interactions
Caughey, B., Baron, G. S., Chesebro, B., & Jeffrey, M. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.78.082907.145410 · Cited by 323
Prions and their partners in crime
Caughey, B., & Baron, G. S. (2006) · Nature · doi:10.1038/nature05294 · Cited by 295
Kang, S.-W., Rane, N. S., Kim, S. J., Garrison, J. L., Taunton, J., & Hegde, R. S. (2006) · Cell · doi:10.1016/j.cell.2006.10.032 · Cited by 288
Protein targeting and degradation are coupled for elimination of mislocalized proteins
Hessa, T., Sharma, A., Mariappan, M., Eshleman, H. D., Gutierrez, E., & Hegde, R. S. (2011) · Nature · doi:10.1038/nature10181 · Cited by 271
Choi, C. J., Kanthasamy, A., Anantharam, V., & Kanthasamy, A. G. (2006) · NeuroToxicology · doi:10.1016/j.neuro.2006.06.004 · Cited by 88
Shah, S. Z. A., Zhao, D., Hussain, T., & Yang, L. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.09.004 · Cited by 55
Rezaie, P., Pontikis, C. C., Hudson, L., Cairns, N. J., & Lanto, P. L. (2005) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.4a6551.2005 · Cited by 32
Metadata
- Authors
- Ma, J., Wollmann, R., & Lindquist, S.
- Venue
- Science
- Published
- 2002-11-29
- Volume
- 298
- Issue
- 5599
- Pages
- 1781-1785
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2077404304
- Cited by
- 487
- References
- 36
- FWCI
- 16.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.